BRAIN & COMPANY
Babak Kateb, MD is a neuroscientist with more than 15 years of research experience. His research has been focused on introduction of advance diagnostics and therapeutics into clinical neuroscience in order to rapidly identify and introduce game changing technologies to treat neurological disorders such as brain cancer, Alzheimer’s disease, Parkinson’s disease, brain and spinal disorders. He did his Research fellowship at USC department of neurosurgery and also studied Neuroengineering at USC Ming Hsieh Institute.\\\\r\\\\n\\\\r\\\\nBabak established Society for Brain Mapping and Therapeutics (SBMT) while doing his fellowship 13 years ago at USC. Currently, he is the founding chairman of the board of directors & CEO Society for Brain Mapping and Therapeutics (SBMT), President and Scientific Director of the Brain Mapping Foundation and Director of National Center for Nano-Bio-Electronics.; the center is focused on integration of nanotechnology, cellular therapeutics/stem cell, medical device and imaging. He was Director of Research and Development at the Department of Neurosurgery at City of Hope Cancer Center. He is also Research Scientist at Department of Neurosurgery at Cedars Sinai Medical center. He is recipient of NASA Tech Brief Award for his pioneering work on sniffing cancer cells using NASA’s electronic nose. He has pioneered the technique for using NASA Multiwall carbon nanotubes to activate macrophages for brain cancer immunotherapy and recently has received an approval from the FDA to microwave soft tissue. The technology also could be used for brain, liver, head and neck, prostate and breast cancer. \\\\r\\\\nIn 2015 Society for Brain Mapping and Therapeutics and Brain Mapping Foundation Board of Directors presented him with Pioneer in Medicine award. He has been recognized by Mayor of Los Angeles and Governor of California for his dedication in science. He is currently collaborating with Los Alamos National Lab and has duel appointment with NASA/JPL as a visiting scientist. His research at NASA and LANL involves the use of Artificial Intelligence and Supercomputing for Brain Mapping and therapeutics, use of electronic nose for cancer detection, application of new UV imaging for intraoperative brain mapping and use of LANL advance ultrasonic technology for brain stimulation; Babak has many patents in these areas. He has established a new publication with PLoSOne, which is called PLoSOne_ NeuroMapping & Therapeutics, which he serves as editor in chief and was the force behind 3 successful NeuroImage-Brain Mapping and Therapeutics special issues. He is editor of The inaugural Textbook of Nanoneuroscience and Nanoneurosurgery, published by, Taylor & Francis 2013 and the editor of the inaugural textbook of Neurophotonic and Brain Mapping, which is due for a release for Dec. 2015. He has been deeply involved in global neuroscience legislation through his close collaboration with the US Congressional Neuroscience Caucus as well as members of Canadian Parliaments. He has chaired 3 congressional briefing on Brain Mapping and given a talk to the Canadian Parliament. His initiatives have impacted the health care delivery to the wounded soldiers in the US. He has been one of the key players in President Obama’s BRAIN initiative and co-author of the G20 World Brain Mapping and Therapeutics Initiative and African Brain Mapping Initiative. He is also 13 times Marathon runner.
Introduction of advance diagnostics and therapeutics into clinical neuroscience in order to rapidly identify and introduce game changing technologies to treat neurological disorders such as brain cancer, Alzheimer’s disease, Parkinson’s disease, brain and spinal disorders.